|
|
|
| A Cost Analysis of Three PET/CT Facilities |
| ZHANG Hong-yu |
| PET/CT Center, Shanxi Province Tumor Hospital, Shanxi Province Taiyuan 030013, China |
|
|
|
|
Abstract The aim of this study was to conduct a cost and efficiency analysis of PET/CT institutions, and how to collocate and utilize PET/CT device and related medical resource were expatiated. Three PET facilities were investigated about the costs and efficiency (Two facilities that using delivery FDG, one facility that had cyclotron, which can produce FDG by itself); the break-even point was analyzed in each of three institutions. In the three hospitals (A, B and C), the annual number of PET/CT scan were 1238, 802 and 753, respectively, while cost per scan was accounted as 7500 RMB in all three hospitals, the break-even point was calculated to be 1509, 862 and 798, respectively. PET/CT facilities utilizing delivery FDG seemed to have difficulty in business administration. Such a situation suggests the possibility that the current supply of PET/CT facilities might exceed actual demand for the service, which can lead to the medical resource waste. The efficiency of resource allocation should be taken into consideration by the government and health service researches on PET/CT and related medical devices in the future.
|
|
Received: 20 March 2017
|
|
|
|
Corresponding Authors:
ZHANG Hong-yu. E-mail: hongyuzhang2008@sina.cn
|
|
|
|
[1] McCarthy M, Yuan JB, Campbell A, et al.18F-fluorodeoxyglucose positron emission tomography imaging in brain tumors: the Western Australia positron emission tomography/cyclotron service experience[J]. Journal of Medical Imaging and Radiation Oncology, 2008, 52(6): 564-569.
[2] Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions[J]. Radiology, 2006, 238(2): 405-422.
[3] Hutchings M, Mikhaeel NG, Fields PA, et al. Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma[J]. Annals of Oncology, 2005,16(7):1160-1168.
[4] Kapre NM, Dabholkar JP. PET scan in head and neck tumours in a developing country like india: Is it a must[J]? Indian Journal of Otolaryngology & Head & Neck Surgery, 2014, 66: 97.
[5] Werner P, Rullmann M, Bresch A, et al. Impact of attenuation correction on clinical [18F]FDG brain PET in combined PET/MRI[J]. EJNMMI Research, 2016, 6: 47.
[6] Puri V, Meyers BF. Utility of positron emission tomography in the mediastinum: moving beyond lung and esophageal cancer staging[J]. Thoracic Surgery Clinics, 2009,19(1): 7-15.
[7] MacManus M, Nestle U, Rosenzweig KE, et al. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007[J]. Radiotherapy and Oncology, 2009, 91(1): 85-94.
[8] Brusamolino E, Bacigalupo A, Barosi G, et al. Classical Hodgkin’s lymphoma in adults: guidelines of the Italian Society of hematology, the Italian Society of Experimental hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up[J]. Haematologica, 2009, 94(4): 550-565.
[9] Vinjamuri S, Ray S. Added value of PET and PET-CT in oesophageal cancer: a review of current practice[J]. Nuclear Medicine Communications, 2008, 29(1): 4-10.
[10] Kumar R, Shandal V, Shamim SA, et al. Clinical applications of PET and PET/CT in pediatric malignancies[J]. Expert Review of Anticancer Therapy, 2010, 10(5): 755-768. |
|
|
|
